The global sleep monitoring devices market size was USD 19.68 billion in 2023, estimated at USD 22.97 billion in 2024 and is anticipated to reach around USD 104.14 billion by 2034, expanding at a CAGR of 16.32% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Sleep Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Sleep Monitoring Devices Market Revenue and Volume, by Component, 2024-2034
8.1.1. Hardware
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Software & Solutions
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Sleep Monitoring Devices Market Revenue and Volume, by Operating System, 2024-2034
9.1.1. Android
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. IOS
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Component (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by Operating System (2021-2034)
11.1. ResMed Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Fitbit, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Philips Healthcare
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Garmin Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Withings (Nokia Health)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Apple Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Sleep Number Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Xiaomi Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Oura Health Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Emfit Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample